Tallinn-based life sciences compliance startup Validfor has raised $1.2 million in a pre-seed round led by DOMiNO Ventures, with participation from Curiosity VC and a group of angel investors, as it looks to modernize validation processes across pharma, biotech, and medtech. The company is building an AI-native, agentic digital validation platform that replaces fragmented, document-heavy compliance workflows with automated, audit-ready systems capable of managing the full GxP lifecycle. With the fresh capital, Validfor plans to accelerate product development, expand its engineering team, and roll out new features such as autonomous testing, while scaling adoption among global life sciences companies.
Validfor is a B2B startup transforming Life Sciences compliance with AI-native agentic digital validation platform for Pharma, Biotech, and MedTech companies. The company is shifting the industry away from fragmented, document-heavy validation processes toward autonomous, audit-ready compliance systems. Its AI-native engine structures regulatory documentation, automates validation workflows, and enables companies to manage the full compliance lifecycle faster and with greater accuracy.
In early 2026, Validfor officially launched its agentic digital validation platform, positioning itself as an AI-native validation solution for pharmaceutical and life sciences companies. The platform enables structured, audit-ready GxP validation with go-live timelines as short as 4 weeks, significantly faster than traditional validation lifecycles which can take at least 4 months. By combining agentic AI with digital validation workflows, Validfor is redefining how regulated organizations approach compliance, audit preparation, and documentation management across global pharma operations.
Pharmaceutical compliance remains highly manual and operationally complex, with billions of dollars spent annually on validation labour, audit preparation, and legacy systems. Validfor replaces outdated tools with an intelligent, end-to-end platform that automates routine compliance tasks while maintaining human oversight for critical decisions. This approach reduces operational burden and helps organizations adapt to increasingly demanding regulatory standards.
Omer Cimen, Co-Founder and CEO at Validfor, said: “Compliance is evolving from documentation to intelligence. As regulatory complexity increases, only agentic, data-driven systems will be able to manage lifecycle validation at scale. Validfor is building the digital backbone that will power the next generation of pharma compliance. This funding accelerates our mission to modernize compliance globally and will allow us to immediately scale our engineering team to integrate new capabilities like Autonomous Testing in Q2.”
DOMiNO Ventures and Curiosity VC are fully confident that Validfor will reshape the validation software space.
“We see a strong team with exceptional execution and dedication, which is why we invested alongside Curiosity VC to support Validfor’s international growth,” said Mustafa Kopuk from DOMiNO Ventures.
Click to read more funding news.
Read the orginal article: https://arcticstartup.com/validfor-raises-1-2m-pre-seed/
